Financials
Financial year 2025
RENAL from Ouffet, company number BE0760953914, closed financial year 2025 with a result of € -24,692 after tax. For that financial year RENAL recorded a gross margin of € -4,473 and equity of € 543,691. Compared with financial year 2024, the result moved from € 3,576 to € -24,692. The company made a loss. The company holds a healthy buffer. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 29, 2026.
€ 543,691
▼ 4% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -24,692
▼ still € 3,576 profit in 2024
Profit after tax over the fiscal year.
€ 44,387
▼ 20% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -29,061.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 363
▼ 93% vs 2024
Supplier invoices still open on the last day of the fiscal year.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 33,066 | € 15,832 | € 23,995 | € -4,473 | ▼ € 28,468 |
| Profit after taxes | € 16,394 | € -4,543 | € 3,576 | € -24,692 | ▼ € 28,269 |
| Equity | € 569,350 | € 564,807 | € 568,383 | € 543,691 | ▼ 4% |
| Total debts | € 11,981 | € 7,163 | € 7,399 | € 2,513 | ▼ 66% |
| Cash | € 43,603 | € 38,375 | € 55,499 | € 44,387 | ▼ 20% |
| Land & buildings | € 502,732 | € 494,593 | € 486,693 | € 476,356 | ▼ 2% |
| Retained profit | € -3,402 | € -7,945 | € -4,369 | € -29,061 | ▼ € 24,692 |
| Balance sheet total | € 581,331 | € 571,970 | € 575,783 | € 546,204 | ▼ 5% |
Key figures of RENAL, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to RENAL?
What happened at RENAL in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 24,692 (▼ € 28,269 vs 2024). Source: NBB ↗
- New establishment in Ouffet. KBO
- Alain DE VOS became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 16,394 profit in 2022 to € 24,692 loss in 2025.
Best year ever: 2022, with € 16,394 profit.
Management
Behind RENAL is Alain DE VOS.
Directors
According to the 2025 annual accounts
Alain DE VOS
Managing director
since 2021
Establishments
Establishment units
Physical locations of this company
Renal 1-2
4590 Ouffet
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0760.953.914
- VAT number
- BE 0760.953.914
- Registered office
- Renal 1-2, 4590 Ouffet
- Names & denominations
- RENAL
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 7 January 2021
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Verhuur en exploitatie van eigen of geleased residentieel onroerend goed, exclusief sociale woningen
Ondersteunende activiteiten in verband met de teelt van gewassen
Verhuur en exploitatie van eigen of geleased niet-residentieel onroerend goed, exclusief terreinen
Behandeling van gewassen na de oogst en van zaden voor vermeerdering
Exploitatie van bossen
Bosbouw en bosbouwactiviteiten